Table 5.
No of vaccines | No receiving vaccine | Asthma | Hay fever | Eczema or psoriasis |
---|---|---|---|---|
Before deployment | ||||
0/1 | 157 | 1.0 | 1.0 | 1.0 |
2 | 142 | 0.9 (0.3 to 2.4) | 0.7 (0.4 to 1.2) | 0.8 (0.3 to 1.9) |
3 | 122 | 0.5 (0.1 to 1.6) | 0.9 (0.5 to 1.6) | 1.4 (0.6 to 3.2) |
4 | 131 | 1.0 (0.4 to 2.7) | 0.9 (0.5 to 1.7) | 1.1 (0.5 to 2.7) |
⩾5 | 74 | 1.0 (0.3 to 3.2) | 1.0 (0.5 to 1.9) | 1.4 (0.6 to 3.8) |
χ2=0.00 (0.99) | χ2=0.06 (0.81) | χ2=0.93 (0.3) | ||
During deployment | ||||
0/1 | 193 | 1.0 | 1.0 | 1.0 |
2 | 103 | 2.4 (0.8 to 7.6) | 1.6 (0.9 to 2.9) | 2.2 (1.0 to 4.9) |
3 | 108 | 2.2 (0.7 to 7.0) | 1.3 (0.7 to 2.3) | 1.0 (0.3 to 2.5) |
4 | 172 | 2.3 (0.8 to 6.6) | 0.9 (0.5 to 1.6) | 0.9 (0.4 to 2.1) |
⩾5 | 70 | 3.3 (1.0 to 10.8) | 1.4 (0.7 to 2.8) | 1.7 (0.7 to 4.4) |
χ2=3.5 (0.06) | χ2=0.01 (0.94) | χ2=0.01 (0.92) |